Self-Management Program for Amputation
(SMART Trial)
Trial Summary
What is the purpose of this trial?
Lower Limb Amputations (LLAs) are a substantial burden on the Canadian health services with nearly 50,000 cases reported between 2006 and 2011. To address the challenging nature of a LLA (e.g., decreased mobility, pain, depression), patients need to go through extensive rehabilitation programs. Effective self-management programs can help those with LLA to monitor their own condition and improve their quality of life. However, a lack of self-management programs, a limited healthcare budget, and a decrease in quality of services (e.g. shorter lengths of stay for inpatients and rapid movement to outpatient services) pose further challenges for patients with LLA. Self-management programs can be provided to clients through online mobile technologies (e.g., tablet) and offer accessible, low-cost, and potentially augmentative rehabilitation after discharge, in both urban and rural areas. To address these needs, an online educational and training platform for individuals with LLA called, Self-Management for Amputee Rehabilitation using Technology (SMART) was designed and developed. SMART focuses on LLA education, prosthetic limb management, and weekly support of peers. It is monitored by a trainer through a website. SMART will be evaluated in men and women with LLA aged 50 years and over, admitted to prosthetic rehabilitation throughout BC and ON. SMART has the potential to influence a client's post-LLA needs with direct (e.g., individual's health) and indirect (e.g., healthcare utilization) benefits. The purpose of this randomized controlled trial is to evaluate the effect of SMART in community dwelling older adults with unilateral, above or below, knee amputation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on self-management and rehabilitation, so it's likely you can continue your current meds, but you should confirm with the trial coordinators.
What data supports the effectiveness of the treatment Self-Management for Amputee Rehabilitation Using Technology?
How is the Self-Management Program for Amputation different from other treatments for amputees?
The Self-Management Program for Amputation is unique because it focuses on empowering individuals to manage their own rehabilitation using technology, which may include telehealth and self-assessment tools, rather than relying solely on standard care or support groups. This approach aims to improve outcomes by encouraging active participation in the rehabilitation process.24678
Research Team
William C Miller, PhD
Principal Investigator
The University of British Columbia
Eligibility Criteria
This trial is for English-speaking adults over 50 in British Columbia or Ontario, Canada, who have had one lower limb amputated above or below the knee due to diabetes or vascular disease. They must have received their initial prosthesis casting within the last two years and have access to a computer or tablet with internet.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the SMART intervention or control care booklet for 6 weeks. The SMART group uses a tablet for daily self-management activities, including mental and physical wellness, prosthetic limb management, and weekly peer-support calls.
Retention Effect
The retention effect of the SMART program is assessed for 4 weeks after the initial treatment phase.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of ambulation confidence and walking capacity.
Treatment Details
Interventions
- Control
- SMART
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator